Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara-C) penetration into the cerebrospinal fluid during high-dose Ara-C therapy?-Reference-Cited by-同舟云学术

Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara-C) penetration into the cerebrospinal fluid during high-dose Ara-C therapy?

Published:2009-04-24 Issue:1 Volume:36 Page:123-126
ISSN:0036-553X
Container-title:Scandinavian Journal of Haematology
language:en
Short-container-title:

Author:

Prooijen Hendrik C.,Muus Petra,Roelofs Jan M. M.,Punt Kees

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1986.tb02664.x/fullpdf

Reference9 articles.

1. Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside;Frick;J Clin Oncol,1984

2. A pilot study of high-dose 1-p-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: Clinical response and pharmacology;Early;Cancer Res,1982

3. The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy;Slevin;Med Pediatr Oncol,1982

4. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD Ara-C);Breithaupt;Cancer,1982

5. Cerebrospinal fluid concentrations of cytosine arabinoside during intravenous therapy with intermediate dose. A preliminary report;Prooijen;Br J Haematol,1985

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia;Medicine;2014-12

2. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia clinical results in 46 patients;Cancer;1993-07-15

3. The disposition of cytosine arabinoside and its metabolite after single doses to rabbits;Biopharmaceutics & Drug Disposition;1990-03